Clinical trials recruiting for Brain Diseases

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Multi-domain Lifestyle Intervention Among Aged Community-residents in Zhejiang, China
  NCT05886114 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years to 80 Years · Sex: All (male and female) · 1 location
• Amygdala Memory Enhancement
  NCT05065450 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Biobank and Brain Health in Bordeaux.
  NCT05322343 · Phase: Not specified · Ages: 55 Years to 80 Years · Sex: All (male and female) · 3 locations
• CUHK Brain Health Longitudinal Study
  NCT03592563 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation
  NCT06954610 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Clinical Indicators and Brain Image Data: a Study Based on Kailuan Cohort
  NCT05453877 · Phase: Not specified · Ages: 18 Years to 90 Years · Sex: All (male and female) · 2 locations
• DOAC in Chinese Patients With Atrial Fibrillation
  NCT05378035 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Selective Activation of the Adrenomedullin Receptors in Migraine
  NCT07451769 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands
  NCT06193252 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years and older · Sex: All (male and female) · 1 location
• Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
  NCT06993142 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years and older · Sex: All (male and female) · 2 locations
• Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity
  NCT07324330 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 80 Years · Sex: All (male and female) · 1 location
• Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
  NCT05386108 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 86 locations
• Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia
  NCT06088121 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years to 85 Years · Sex: All (male and female) · 11 locations
• Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application
  NCT03678194 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• University of Central Florida CereBank
  NCT06876857 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · 1 location

Related conditions

Trials recruiting for Brain Diseases often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Brain Diseases trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.